Skip to main content
Stephanie Berg, DO, Oncology, Boston, MA, Dana-Farber Cancer Institute

StephanieAnnBergDO

Oncology Boston, MA

Genitourinary Oncology

Instructor of Medicine, Harvard Medical School, Department of Medical Oncology, Dana-Farber Cancer Institute

Dr. Berg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Berg's full profile

Already have an account?

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoChief Residency, Internal Medicine, 2014 - 2015
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2011 - 2014
  • Lake Erie College of Osteopathic Medicine Bradenton Campus
    Lake Erie College of Osteopathic Medicine Bradenton CampusClass of 2011
  • University of Miami
    University of MiamiBS, Biology, 2001 - 2005

Certifications & Licensure

  • IL State Medical License
    IL State License 2011 - 2026
  • MA State Medical License
    MA State License 2022 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • ACLS ACLS

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Immunological and clinical profiles of patients with advanced or metastatic melanoma receiving immune checkpoint inhibitors to investigate potential biomarkers for imm... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Study Shows Structural Racism Can Result in Poorer Leukemia Outcomes
    Study Shows Structural Racism Can Result in Poorer Leukemia OutcomesMarch 7th, 2022
  • DCVAC/PCa Use Alongside Chemotherapy Shows No Additional mCRPC Survival Benefit
    DCVAC/PCa Use Alongside Chemotherapy Shows No Additional mCRPC Survival BenefitFebruary 28th, 2022
  • Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancer
    Active Cellular Immunotherapy Disappoints in Metastatic Prostate CancerFebruary 10th, 2022

Committees

  • Executives Officer, Experimental Therapeutics and Rare Tumors, Alliance for Clinical Trials in Oncology 2021 - Present

Professional Memberships

Hospital Affiliations